Search for the best weight-loss injection in the UK and you'll find plenty of confident answers — many written before the market changed. In 2026 three licensed options are worth comparing: Mounjaro (tirzepatide), Wegovy (semaglutide) and, new this year, the needle-free Wegovy pill (oral semaglutide). Each is "best" at something different.
This guide puts all three side by side on the measures that separate them: trial weight loss, evidence base, fit with daily life, and monthly cost. Every price below comes from our tracker of 24 regulated UK providers, last checked 4 July 2026.
Key takeaway: Mounjaro delivers the largest average weight loss (around 21–22% at the higher doses over 72 weeks). Wegovy has the longest track record and is the only option shown to cut heart-attack and stroke risk in people with existing heart disease. The Wegovy pill trades a little effectiveness for no needles. Whichever you choose, the same dose can cost up to £90 a month more at one provider than another — compare before you commit.
The 2026 field: three licensed options
Mounjaro (tirzepatide)
Mounjaro is the only dual-hormone option — a "twincretin" mimicking both GIP and GLP-1 gut hormones. It's a once-weekly injection, starting at 2.5 mg and stepping up to a maximum of 15 mg. In SURMOUNT-1, participants averaged 21.4% loss at 10 mg and 22.5% at 15 mg over 72 weeks, versus 2.4% on placebo.
Wegovy (semaglutide)
Wegovy is a GLP-1-only weekly injection and the most established dedicated weight-loss jab in the UK. In STEP 1, the 2.4 mg dose averaged about 15% body-weight loss over 68 weeks. Since January 2026 the MHRA has also approved a higher 7.2 mg dose for obesity (BMI 30+), now stocked by 8 of our 24 tracked providers.
Wegovy pill (oral semaglutide)
The newest arrival puts Wegovy's active ingredient in a daily tablet — the UK's first needle-free GLP-1. It's taken on an empty stomach with a 30-minute wait before eating, and the dose builds over roughly 12 weeks to the full 25 mg. Availability is thin: just 2 of our 24 tracked providers list it.
Head-to-head: the numbers that matter
| Mounjaro | Wegovy | Wegovy pill | |
|---|---|---|---|
| Active ingredient | Tirzepatide (dual GIP + GLP-1) | Semaglutide (GLP-1) | Semaglutide (GLP-1, oral) |
| How it's taken | Weekly injection, 2.5–15 mg | Weekly injection, 0.25–2.4 mg (7.2 mg now approved) | Daily tablet, 1.5–25 mg, empty stomach |
| Average trial weight loss | 21.4–22.5% at 10–15 mg over 72 weeks (SURMOUNT-1) | ~15% at 2.4 mg over 68 weeks (STEP 1) | ~13.6% at 25 mg over 64 weeks (OASIS 4) |
| Standout strength | Largest average weight loss | Longest track record; proven heart benefit (SELECT) | No needles |
| Starter month from | £145.99 | £79.97 | £99.00 |
| Top maintenance dose from | £288.99 (15 mg) | £174.99 (2.4 mg) | £190.00 (25 mg) |
| Providers stocking it | 24 of 24 tracked | 24 of 24 tracked | 2 of 24 tracked |
"From" prices are the cheapest per 4 weeks among our 24 tracked UK providers, last checked 4 July 2026. The trials enrolled different populations over different durations, so cross-trial percentages are a guide, not a precise ranking.
Best for sheer weight loss: Mounjaro
If your only yardstick is kilograms lost, Mounjaro leads — and not narrowly. About 90% of participants on 15 mg lost at least 10% of their body weight, and in SURMOUNT-5, the head-to-head trial against Wegovy, tirzepatide came out ahead at roughly 20% average loss versus about 14%.
The trade-offs are cost and side effects. Mounjaro's cheapest starter month (£145.99) is nearly double Wegovy's, and its top dose is the dearest maintenance option on the market. Common side effects — nausea, diarrhoea, constipation, vomiting, tiredness — match the rest of the class; our side-effect comparison covers the differences.
Best for track record — and heart protection: Wegovy
Wegovy has been prescribed in the UK longer than any rival, so it carries the most trial data and real-world experience. It also holds one card Mounjaro can't yet match: in the SELECT trial it cut heart-attack and stroke risk in people with existing cardiovascular disease — the only weight-loss injection with that proof.
It's also the cheapest way in: a starter month costs from £79.97, the lowest of the three. If around 15% average loss meets your goal — and for many people it does — the case for paying more is weaker than the headlines suggest. For a feature-by-feature breakdown, see our guide to how Mounjaro, Wegovy and the rest differ.
Want a clinician's view?
The Weight Clinic — our recommended provider — stocks all three treatments, with a free consultation, monthly video reviews with a clinician, and a refund if the prescriber declines you. Code NEWME takes £35 off a first order: Mounjaro's first month drops to £125, Wegovy or the pill to £80.
Check your eligibility at The Weight Clinic → Prescription-only medicines. A prescriber decides whether treatment is right for you.Best if you'd rather skip needles: the Wegovy pill
For some people the deciding factor is never having to inject. In OASIS 4 the 25 mg tablet averaged about 13.6% body-weight loss over 64 weeks — around 16.6% among those who took it consistently — and roughly 30% of participants lost at least a fifth of their body weight.
The catch is discipline: a daily dose on an empty stomach with a 30-minute wait before breakfast, and about three months of dose steps to reach full strength. Supply is limited too, and with only two tracked providers there's little price competition. A starter month runs from £99, the 25 mg dose from £190.
What "best" costs in July 2026
Price is where care pays off fastest: the medicine is identical whatever you pay. Across our 24 tracked providers, a starter month of Wegovy spans £79.97 to £164 — an £84 spread for the same pen. Mounjaro's runs £145.99 to £229, and at Wegovy's 1 mg dose the gap hits £90 a month.
The number that matters is the ongoing dose, not the starter promo: Wegovy 2.4 mg from £174.99, Mounjaro 15 mg from £288.99, the pill's 25 mg from £190 per four weeks. Our full price comparison breaks this down dose by dose, and the live tables on our homepage are re-checked regularly — always confirm the current price on the provider's own site.
So which is the best weight-loss injection in the UK?
It depends on which "best" you mean:
- Most weight loss: Mounjaro, on every trial measure to date.
- Most evidence and heart protection: Wegovy, with the longest UK record and the SELECT result.
- No needles: the Wegovy pill, if you can live with the morning routine.
- Tightest budget: compare maintenance-dose prices, not starter offers — the gap between providers is often bigger than the gap between drugs.
Two cautions. First, eligibility comes before preference: UK prescribers typically require a BMI of 30+, or 27+ with a weight-related condition, and the prescriber makes the final call. Second, these medicines carry side effects and none suits everyone. Still weighing it up? Our step-by-step framework for choosing a weight-loss injection walks through the decision in order.
Frequently asked questions
What is the strongest weight-loss injection available in the UK?
On trial averages, Mounjaro (tirzepatide): 21.4% of body weight lost at 10 mg and 22.5% at 15 mg over 72 weeks in SURMOUNT-1, and around 20% versus roughly 14% for Wegovy in the SURMOUNT-5 head-to-head. Results vary widely, and the strongest option isn't automatically right for you — that's a prescriber's call.
How much do weight-loss injections cost per month in the UK?
Across the 24 regulated providers we track, a starter month of Wegovy ranges from £79.97 to £164 and Mounjaro from £145.99 to £229. Ongoing doses cost more — Wegovy 2.4 mg from £174.99 and Mounjaro 15 mg from £288.99 per four weeks. The same dose can vary by up to £90 a month between providers.
Can I choose which weight-loss injection I'm prescribed?
You can ask a provider for a specific treatment, but the prescriber makes the final decision. They'll check your BMI (typically 30+, or 27+ with a weight-related condition), medical history and current medicines, and may recommend a different option or decline to prescribe.
Is the Wegovy pill as effective as the injections?
Nearly. The 25 mg daily tablet averaged about 13.6% loss over 64 weeks in OASIS 4 — close to injectable Wegovy's roughly 15%, well short of Mounjaro's 21–22%. It demands a strict empty-stomach morning routine, and only 2 of the 24 UK providers we track stock it.
Ready to talk to a prescriber?
If you want Mounjaro, Wegovy and the Wegovy pill under one roof, The Weight Clinic is our recommendation: free consultation, monthly video reviews, next-day delivery with needles included — and a refund if the prescriber decides treatment isn't right for you. Code NEWME takes £35 off your first order.
Start your free consultation → Prescription-only medicines with real side effects. Approval is never guaranteed — and shouldn't be.This article is price and product information, not medical advice. Talk to your GP or pharmacist before starting any weight-loss medicine, and report suspected side effects via the MHRA Yellow Card scheme.